BIO-TECHNE Corp Operating Leases, Future Minimum Payments, Due Thereafter
BIO-TECHNE Corp (TECH) had Operating Leases, Future Minimum Payments, Due Thereafter of $51.90 million as of 2019-06-30, per its 10-K filed 2020-08-26.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter · last filed 2020-08-26
- 2019-06-30: Operating Leases, Future Minimum Payments, Due Thereafter $51.90M.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due Thereafter $37.90M.
- 2017-06-30: Operating Leases, Future Minimum Payments, Due Thereafter $26.73M.
- 2016-06-30: Operating Leases, Future Minimum Payments, Due Thereafter $19.12M.
| Period end | Operating Leases, Future Minimum Payments, Due Thereafter | Operating Leases, Future Minimum Payments, Due Thereafter as first filed |
|---|---|---|
| 2019-06-30 | $51.90M 10-K · filed 2020-08-26 | |
| 2018-06-30 | $37.90M 10-K · filed 2018-08-27 | |
| 2017-06-30 | $26.73M 10-K · filed 2017-09-07 | |
| 2016-06-30 | $19.12M 10-K · filed 2016-08-29 | |
| 2015-06-30 | $22.49M 10-K · filed 2015-08-31 | |
| 2014-06-30 | $7.73M 10-K · filed 2014-08-29 | |
| 2012-06-30 | $283.00K 10-K · filed 2013-08-29 | $396.00K 10-K · filed 2012-08-29 |
| 2011-06-30 | $549.00K 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |